Literature DB >> 22209851

Lipopolysaccharide affects exploratory behaviors toward novel objects by impairing cognition and/or motivation in mice: Possible role of activation of the central amygdala.

Ryota Haba1, Norihito Shintani, Yusuke Onaka, Hyper Wang, Risa Takenaga, Atsuko Hayata, Akemichi Baba, Hitoshi Hashimoto.   

Abstract

Lipopolysaccharide (LPS) produces a series of systemic and psychiatric changes called sickness behavior. In the present study, we characterized the LPS-induced decrease in novel object exploratory behaviors in BALB/c mice. As already reported, LPS (0.3-5 μg/mouse) induced dose- and time-dependent decreases in locomotor activity, food intake, social interaction, and exploration for novel objects, and an increase in immobility in the forced-swim test. Although the decrease in locomotor activity was ameliorated by 10h postinjection, novel object exploratory behaviors remained decreased at 24h and were observed even with the lowest dose of LPS. In an object exploration test, LPS shortened object exploration time but did not affect moving time or the frequency of object exploration. Although pre-exposure to the same object markedly decreased the duration of exploration and LPS did not change this reduction, LPS significantly impaired the exploration of a novel object that replaced the familiar one. LPS did not affect anxiety-like behaviors in open-field and elevated plus-maze tests. An LPS-induced increase in the number of c-Fos-immunoreactive cells was observed in several brain regions within 6h of LPS administration, but the number of cells quickly returned to control levels, except in the central amygdala where the increase continued for 24h. These results suggest that LPS most prominently affects object exploratory behaviors by impairing cognition and/or motivation including continuous attention and curiosity toward objects, and that this may be associated with activation of brain nuclei such as the central amygdala.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22209851     DOI: 10.1016/j.bbr.2011.12.027

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  28 in total

1.  Repeated LPS Injection Induces Distinct Changes in the Kynurenine Pathway in Mice.

Authors:  M K Larsson; A Faka; M Bhat; S Imbeault; M Goiny; F Orhan; A Oliveros; S Ståhl; X C Liu; D S Choi; K Sandberg; G Engberg; L Schwieler; S Erhardt
Journal:  Neurochem Res       Date:  2016-05-10       Impact factor: 3.996

2.  Role of brain transmigrating neutrophils in depression-like behavior during systemic infection.

Authors:  A Aguilar-Valles; A Aguliar-Valles; J Kim; S Jung; B Woodside; G N Luheshi
Journal:  Mol Psychiatry       Date:  2013-10-15       Impact factor: 15.992

Review 3.  Gut microbiota in autism and mood disorders.

Authors:  Francesca Mangiola; Gianluca Ianiro; Francesco Franceschi; Stefano Fagiuoli; Giovanni Gasbarrini; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

4.  Compensatory recovery of blood glucose levels in KKA(y) mice fed a high-fat diet: insulin-sparing effects of PACAP overexpression in β cells.

Authors:  Yusuke Sakurai; Hiroaki Inoue; Norihito Shintani; Akihiro Arimori; Ken-ichi Hamagami; Atsuko Hayata-Takano; Akemichi Baba; Hitoshi Hashimoto
Journal:  J Mol Neurosci       Date:  2012-04-03       Impact factor: 3.444

5.  Indoleamine 2,3-dioxygenase-dependent neurotoxic kynurenine metabolism mediates inflammation-induced deficit in recognition memory.

Authors:  Jillian M Heisler; Jason C O'Connor
Journal:  Brain Behav Immun       Date:  2015-06-27       Impact factor: 7.217

Review 6.  Immune activation and neuroinflammation in alcohol use and HIV infection: evidence for shared mechanisms.

Authors:  Mollie A Monnig
Journal:  Am J Drug Alcohol Abuse       Date:  2016-08-17       Impact factor: 3.829

7.  Neuroanatomical and functional characterization of CRF neurons of the amygdala using a novel transgenic mouse model.

Authors:  P N De Francesco; S Valdivia; A Cabral; M Reynaldo; J Raingo; I Sakata; S Osborne-Lawrence; J M Zigman; M Perelló
Journal:  Neuroscience       Date:  2015-01-13       Impact factor: 3.590

8.  Central CRTH2, a second prostaglandin D2 receptor, mediates emotional impairment in the lipopolysaccharide and tumor-induced sickness behavior model.

Authors:  Ryota Haba; Norihito Shintani; Yusuke Onaka; Takuya Kanoh; Hyper Wang; Risa Takenaga; Atsuko Hayata; Hiroyuki Hirai; Kin-ya Nagata; Masataka Nakamura; Atsushi Kasai; Ryota Hashimoto; Kazuki Nagayasu; Takanobu Nakazawa; Hitoshi Hashimoto; Akemichi Baba
Journal:  J Neurosci       Date:  2014-02-12       Impact factor: 6.167

9.  Prostaglandins mediate zymosan-induced sickness behavior in mice.

Authors:  Juliana B M Lima; Clarice C Veloso; Fabiana C Vilela; Alexandre Giusti-Paiva
Journal:  J Physiol Sci       Date:  2016-10-03       Impact factor: 2.781

10.  Candesartan ameliorates impaired fear extinction induced by innate immune activation.

Authors:  María M Quiñones; Lizette Maldonado; Bethzaly Velazquez; James T Porter
Journal:  Brain Behav Immun       Date:  2015-10-28       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.